Pharma Company Postpones Executive Compensation Decisions Amid FCPA Probe
In August 2010, SciClone Pharmaceuticals Inc. disclosed that the SEC and the Justice Department are investigating it for potential violations of the Foreign Corrupt Practices Act.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10